Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Colorcon
Express Scripts
Mallinckrodt
AstraZeneca

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Drug Price Trends for NDC 61314-0647

See Plans and Pricing

« Back to Dashboard

Average Pharmacy Cost for 61314-0647

Drug Name NDC Price/Unit ($) Unit Date
TOBRAMYCIN-DEXAMETH OPHTH SUSP 61314-0647-25 15.75259 ML 2019-11-20
TOBRAMYCIN-DEXAMETH OPHTH SUSP 61314-0647-05 16.63141 ML 2019-11-20
TOBRAMYCIN-DEXAMETH OPHTH SUSP 61314-0647-25 16.12880 ML 2019-10-23
TOBRAMYCIN-DEXAMETH OPHTH SUSP 61314-0647-10 14.54875 ML 2019-10-23
TOBRAMYCIN-DEXAMETH OPHTH SUSP 61314-0647-05 17.06410 ML 2019-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 61314-0647

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
DEXAMETHASONE 0.1%/TOBRAMYCIN 0.3% SUSP,OPH Sandoz, Inc. 61314-0647-05 5ML 38.28 7.65600 2019-01-01 - 2020-06-30 FSS
DEXAMETHASONE 0.1%/TOBRAMYCIN 0.3% SUSP,OPH Sandoz, Inc. 61314-0647-10 10ML 77.23 7.72300 2019-01-01 - 2020-06-30 FSS
DEXAMETHASONE 0.1%/TOBRAMYCIN 0.3% SUSP,OPH Sandoz, Inc. 61314-0647-25 2.5ML 20.88 8.35200 2019-01-01 - 2020-06-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Dow
Harvard Business School
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.